Compare MYGN & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | DIN |
|---|---|---|
| Founded | 1991 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 446.6M |
| IPO Year | 1996 | 1994 |
| Metric | MYGN | DIN |
|---|---|---|
| Price | $4.65 | $28.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | $7.64 | ★ $29.67 |
| AVG Volume (30 Days) | ★ 1.7M | 383.9K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.11 |
| Revenue | $771,400,000.00 | ★ $879,300,000.00 |
| Revenue This Year | $7.19 | $3.61 |
| Revenue Next Year | $5.64 | $0.41 |
| P/E Ratio | ★ N/A | $26.42 |
| Revenue Growth | 2.33 | ★ 8.25 |
| 52 Week Low | $3.76 | $18.63 |
| 52 Week High | $10.25 | $39.68 |
| Indicator | MYGN | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 38.99 |
| Support Level | $3.93 | $27.52 |
| Resistance Level | $5.63 | $28.64 |
| Average True Range (ATR) | 0.33 | 1.23 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 23.53 | 19.46 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.